Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Ionis Pharmaceuticals patents

Patents where

Current Assignee

Name

Ionis Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7432250 Oligoribonucleotides and ribonucleases for cleaving RNA	Patent 7432250 was granted and assigned to Ionis Pharmaceuticals on October, 2008 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	7432250	October 7, 2008
‌ US Patent 7432249 Oligoribonucleotides and ribonucleases for cleaving RNA	Patent 7432249 was granted and assigned to Ionis Pharmaceuticals on October, 2008 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	7432249	October 7, 2008
‌ US Patent 7101993 Oligonucleotides containing 2′-O-modified purines	Patent 7101993 was granted and assigned to Ionis Pharmaceuticals on September, 2006 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	7101993	September 5, 2006
‌ US Patent 7696345 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation	Patent 7696345 was granted and assigned to Ionis Pharmaceuticals on April, 2010 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	7696345	April 13, 2010
‌ US Patent 7629321 Oligoribonucleotides and ribonucleases for cleaving RNA	Patent 7629321 was granted and assigned to Ionis Pharmaceuticals on December, 2009 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	7629321	December 8, 2009
‌ US Patent 8124745 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation	Patent 8124745 was granted and assigned to Ionis Pharmaceuticals on February, 2012 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	8124745	February 28, 2012
‌ US Patent 7695902 Oligoribonucleotides and ribonucleases for cleaving RNA	Patent 7695902 was granted and assigned to Ionis Pharmaceuticals on April, 2010 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	7695902	April 13, 2010
‌ US Patent 9617540 Compounds and methods for modulating gene expression	Patent 9617540 was granted and assigned to Ionis Pharmaceuticals on April, 2017 by the United States Patent and Trademark Office.	Ionis Pharmaceuticals	Ionis Pharmaceuticals	United States Patent and Trademark Office	9617540	April 11, 2017
‌ US Patent 7399845 6-modified bicyclic nucleic acid analogs	Patent 7399845 was granted and assigned to Ionis Pharmaceuticals on July, 2008 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	7399845	July 15, 2008
‌ US Patent 9005906 Tetrahydropyran nucleic acid analogs	Patent 9005906 was granted and assigned to Ionis Pharmaceuticals on April, 2015 by the United States Patent and Trademark Office.	Ionis Pharmaceuticals	Ionis Pharmaceuticals	United States Patent and Trademark Office	9005906	April 14, 2015
‌ US Patent 11492617 Compositions and methods for modulation of protein aggregation	Patent 11492617 was granted and assigned to Ionis Pharmaceuticals on November, 2022 by the United States Patent and Trademark Office.	Ionis Pharmaceuticals	Ionis Pharmaceuticals	United States Patent and Trademark Office	11492617	November 8, 2022
‌ US Patent 9695418 Oligomeric compounds comprising bicyclic nucleosides and uses thereof	Patent 9695418 was granted and assigned to Ionis Pharmaceuticals on July, 2017 by the United States Patent and Trademark Office.	Ionis Pharmaceuticals	Ionis Pharmaceuticals	United States Patent and Trademark Office	9695418	July 4, 2017
‌ US Patent 7666854 Bis-modified bicyclic nucleic acid analogs	Patent 7666854 was granted and assigned to Ionis Pharmaceuticals on February, 2010 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	7666854	February 23, 2010
‌ US Patent 7235650 Derivatized oligonucleotides having improved uptake and other properties	Patent 7235650 was granted and assigned to Ionis Pharmaceuticals on June, 2007 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	7235650	June 26, 2007
‌ US Patent 7125975 Derivatized oligonucleotides having improved uptake and other properties	Patent 7125975 was granted and assigned to Ionis Pharmaceuticals on October, 2006 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	7125975	October 24, 2006
‌ US Patent 7321828 System of components for preparing oligonucleotides	Patent 7321828 was granted and assigned to Ionis Pharmaceuticals on January, 2008 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	7321828	January 22, 2008
‌ US Patent 9045754 Short antisense compounds with gapmer configuration	Patent 9045754 was granted and assigned to Ionis Pharmaceuticals on June, 2015 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	9045754	June 2, 2015
‌ US Patent 8088904 Tetrahydropyran nucleic acid analogs	Patent 8088904 was granted and assigned to Ionis Pharmaceuticals on January, 2012 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	8088904	January 3, 2012
‌ US Patent 11530410 Methods for treating hypercholesterolemia	Patent 11530410 was granted and assigned to Ionis Pharmaceuticals on December, 2022 by the United States Patent and Trademark Office.	Ionis Pharmaceuticals	Ionis Pharmaceuticals	United States Patent and Trademark Office	11530410	December 20, 2022
‌ US Patent 7276599 Oligonucleotide synthesis with alternative solvents	Patent 7276599 was granted and assigned to Ionis Pharmaceuticals on October, 2007 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	7276599	October 2, 2007
‌ US Patent 8143230 Compounds and methods for modulating expression of PCSK9	Patent 8143230 was granted and assigned to Ionis Pharmaceuticals on March, 2012 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	8143230	March 27, 2012
‌ US Patent 7741457 6-modified bicyclic nucleic acid analogs	Patent 7741457 was granted and assigned to Ionis Pharmaceuticals on June, 2010 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	7741457	June 22, 2010
‌ US Patent 8088746 Bis-modified bicyclic nucleic acid analogs	Patent 8088746 was granted and assigned to Ionis Pharmaceuticals on January, 2012 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	8088746	January 3, 2012
‌ US Patent 7569686 Compounds and methods for synthesis of bicyclic nucleic acid analogs	Patent 7569686 was granted and assigned to Ionis Pharmaceuticals on August, 2009 by the United States Patent and Trademark Office.		Ionis Pharmaceuticals	United States Patent and Trademark Office	7569686	August 4, 2009
‌ US Patent 10087210 Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom	Patent 10087210 was granted and assigned to Ionis Pharmaceuticals on October, 2018 by the United States Patent and Trademark Office.	Ionis Pharmaceuticals	Ionis Pharmaceuticals	United States Patent and Trademark Office	10087210	October 2, 2018

...

Results per page:

493 results

0 selected

493 results

0 selected